Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07744958
What this trial is testing

RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Heinrich-Heine University, Duesseldorf 100
Not applicableStudy completedNCT02969109
What this trial is testing

Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Genomic Health®, Inc. 417
Testing effectiveness (Phase 2)Study completedNCT02500121
What this trial is testing

Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer

Who this might be right for
Urothelial CarcinomaBladder Cancer
Matthew Galsky 108
Post-approval studies (Phase 4)UnknownNCT03274284
What this trial is testing

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

Who this might be right for
Bladder Cancer
Assiut University 20
Not applicableUnknownNCT02886026
What this trial is testing

Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors

Who this might be right for
Bladder Cancer
University Hospital Bispebjerg and Frederiksberg 248
Large-scale testing (Phase 3)UnknownNCT04490993
What this trial is testing

Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 359
Early research (Phase 1)Active Not RecruitingNCT05843448
What this trial is testing

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Who this might be right for
High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 6
Testing effectiveness (Phase 2)Looking for participantsNCT06511648
What this trial is testing

Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations

Who this might be right for
Muscle-invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 90
Not applicableUnknownNCT04588168
What this trial is testing

Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Early research (Phase 1)Study completedNCT06350838
What this trial is testing

Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-muscular Invasive Bladder Cancer
Chengdu CoenBiotech Co., Ltd 10
Very early researchEnded earlyNCT01479348
What this trial is testing

Imaging Study for FdCyd and THU Cancer Treatment

Who this might be right for
Head and Neck NeoplasmsLung NeoplasmsUrinary Bladder Neoplasms+1 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Ended earlyNCT02887248
What this trial is testing

Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder CancerTransitional Cell Carcinoma
SCRI Development Innovations, LLC 3
Not applicableActive Not RecruitingNCT05871008
What this trial is testing

Integrated Actionable Aging Assessment for Cancer Patients Pilot

Who this might be right for
Breast CancerHodgkin LymphomaKidney Cancer+7 more
University of Colorado, Denver 35
Testing effectiveness (Phase 2)Study completedNCT03159143
What this trial is testing

Study of Docetaxel and Oxaliplatin in Metastatic Transitional Cell Cancer (TCC) of the Urothelial Tract

Who this might be right for
Metastatic Transitional Cell Cancer of the Urothelial Tract
Leonard Appleman 22
Large-scale testing (Phase 3)UnknownNCT00054626
What this trial is testing

Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy 700
Not applicableStudy completedNCT00776178
What this trial is testing

Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 68
Not applicableEnrolling By InvitationNCT05195515
What this trial is testing

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life

Who this might be right for
Bladder Cancer
Aarhus University Hospital 2,000
Not applicableStudy completedNCT04946214
What this trial is testing

A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients

Who this might be right for
Prostate CancerProstate AdenocarcinomaRadiation Toxicity
University of Miami 18
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03652298
What this trial is testing

Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners

Who this might be right for
Colorectal CancerBladder CancerProstate Cancer+2 more
Centre Oscar Lambret 19
Next Page